CVR Partners, LP Form 8-K Summary
Business Context and Reporting Period
Date of Report: August 9, 2015
Company: CVR Partners, LP
Event: Entry into a Material Definitive Agreement to acquire Rentech Nitrogen Partners, L.P. ("Rentech Nitrogen") and Rentech Nitrogen GP, LLC.
CVR Partners has entered into an Agreement and Plan of Merger to acquire Rentech Nitrogen through a combination of newly issued CVR Common Units and cash. The transaction involves two merger subsidiaries, Lux Merger Sub 1 LLC and Lux Merger Sub 2 LLC, which will merge with Rentech Nitrogen GP and Rentech Nitrogen, respectively.
Key Financial Metrics and Transaction Terms
Merger Consideration: Each outstanding Rentech Nitrogen Common Unit (excluding certain affiliate units) will be converted into:
- 1.04 newly issued CVR Common Units
- $2.57 in cash
Financing: CVR Partners' general partner, Coffeyville Resources, LLC, has committed to provide term loan financing of up to $150 million to fund the cash portion of the consideration and transaction expenses. The loan has a one-year term.
Termination Fees:
- Expense reimbursement payment: $10,000,000 (under certain circumstances)
- Termination fee payable by Rentech Nitrogen to CVR Partners: $31,200,000
Financial Performance: This filing does not provide revenue, profit, cash flow, margin, or debt metrics for CVR Partners or Rentech Nitrogen. Investors should refer to the respective Form 10-K filings for historical financial data.
Material Changes and Conditions
The completion of the Merger is subject to several closing conditions, including:
- Adoption of the Merger Agreement by a majority of Rentech Nitrogen Common Unit holders.
- Effectiveness of a registration statement on Form S-4.
- Approval for listing of CVR Common Units on the New York Stock Exchange.
- Sale or spin-off of Rentech Nitrogen's Pasadena facility on specified terms.
- Absence of events of default under Rentech Nitrogen's 6.500% Second Lien Senior Secured Notes due 2021.
- Expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act).
Guidance, Outlook, and Governance Changes
Board Composition: Following the closing, the CVR GP Board will increase from seven to eleven seats. The Rentech Nitrogen Unitholders (beneficially owning approximately 59.7% of Rentech Nitrogen Common Units) will have the right to appoint two directors, subject to minimum ownership thresholds (15% for one seat, 7.5% for termination of rights).
Lock-Up and Standstill Provisions: Rentech Nitrogen Unitholders and GSO Capital Partners LP funds are subject to 180-day lock-up periods on CVR Common Units received in the merger and one-year standstill provisions restricting the acquisition of additional units or influencing management.
Registration Rights: CVR Partners must file a registration statement for the public resale of CVR Common Units issued to Rentech Nitrogen Holdings and DSHC within 30 days of closing, with effectiveness required within 120 days.
Risks and Forward-Looking Statements: The transaction is subject to risks including regulatory approvals, unitholder approval, divestiture of the Pasadena facility, integration challenges, and financing availability. No specific revenue or earnings guidance is provided in this filing.
Key Facts for Investor Verification
- Verify the status of the Rentech Nitrogen Pasadena facility divestiture, a specific condition to closing.
- Confirm the approval of the Merger Agreement by Rentech Nitrogen unitholders.
- Monitor the effectiveness of the Form S-4 registration statement and NYSE listing approval.
- Review the full text of the Merger Agreement (Exhibit 2.1) for detailed representations, warranties, and termination rights.
- Assess the impact of the $150 million term loan commitment on CVR Partners' future leverage and liquidity.